News Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023 Continue Reading Previous Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPDNext Accenture Invests in Open Cosmos to Expand Access to Satellite Data Related Stories News Make Named Best AI Automation Platform for 2026 News Quick Custom Intelligence Brings Live, Next-Gen AI to ICE Barcelona 2026 with Modulus News Rent with Clara Launches Multi-Layer Bank Verification to Combat Rising Rental Application Fraud News Dash Social Launches New Publishing and Analytics Integration With Snap News AcuityTec Unveils Product Enhancements Strengthening KYT Intelligence and Global Data Risk Signals News Four Inc. Awarded NASPO ValuePoint® Cloud and Software Solutions Master Agreement
